YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(1)
- Australia(7)
- Austria(1)
- Belgium(3)
- Canada(46)
- China(11)
- Colombia(1)
- Denmark(1)
- Finland(2)
- France(7)
- Germany(33)
- Greece(1)
- Hong Kong(1)
- Hungary(1)
- India(65)
- Ireland(1)
- Israel(2)
- Italia (6)
- Japan(1)
- Luxembourg(1)
- Malta(1)
- Mauritius(1)
- Mexico(1)
- Peru(1)
- Poland(1)
- Portugal(3)
- Singapore(1)
- Slovenia(1)
- South Korea(3)
- Spain(9)
- Sweden(2)
- Switzerland(17)
- Taiwan(2)
- The Czech Republic(1)
- The Netherlands(3)
- Turkey(1)
- Ukraine(1)
- United Kingdom(45)
- United States(568)
- Vietnam(1)
Contract Service Directory
Charles River Laboratories
Company Headquarters
251 Ballardvale St
Wilmington, MA 01887
United States
Company Description
From complete programs to stand-alone assessments, our Safety Assessment experts conduct a full range of in vivo and in vitro studies that comply with worldwide regulatory requirements for the nonclinical development of human and veterinary pharmaceuticals, medical devices, as well as the registration of chemicals, agrochemicals, and biocides.
Contract Service Directory
- ADMET
- Analytical Laboratory Services
- Analytical Validation Studies
- Assay Development
- Bioanalytical Analysis LC/MS/MS
- Bioanalytical Services
- Bioavailability Studies
- Biomarker Research & Validation
- Biomarker Research – Tissue Based
- Biosimilars
- Clinical Analysis
- Contract Research
- Custom Protocols
- Drug Development Services
- Efficacy Testing
- Environmental Analysis
- Feasibility Studies
- Formulation Development
- Gene Therapy & Testing Protocols
- GLP Auditing
- HPLC
- Imaging
- Immunobiology Services
- Immunotoxicity Testing
- In Vitro Testing
- In Vivo Testing
- IND/NDA Submissions
- Lead Optimization
- Mass Spectrometry
- Methods Development
- Methods Validation
- Microbiological Testing
- Nonclinical Research
- Pharmacodynamics
- Pharmacokinetics
- Pharmacology
- Preclinical Study Design
- Preclinical Testing
- Preclinical Testing Formulations
- QA/QC
- R&D Services
- Regulatory Affairs Consultants
- Toxicology Services & Analysis
Contract Services Directory
Content From Charles River Laboratories
-
Every day. Every challenge. Every patient.
Watch what happens when a little girl meets the researchers who worked on the treatment for her ultra-rare disease.Videos Released on 02.28.2018
-
Every Voice
What happens when a patient meets the people that helped save her life?Videos Released on 04.01.2017
Related Content
-
Bioanalytical Services | Breaking News | CRO News | Industry News
Charles River Acquires Retrogenix
Strengthens scientific expertise with the addition of cell microarray technology and off-target profiling for drug discovery.Tim Wright, Editor, Contract Pharma 04.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Charles River Acquires CDMO Cognate BioServices
Pays roughly $875 million to significantly expand capabilities in the cell and gene therapy sector.Tim Wright, Editor, Contract Pharma 02.17.21
-
Breaking News | Collaborations & Alliances
Charles River Partners with JADE
Expands its biologics testing capabilities geographically and helps to accommodate demand for biologics therapeutics.Contract Pharma Staff 01.14.21
-
Breaking News | CRO News | Drug Discovery | Preclinical Outsourcing
Charles River Labs Acquires Distributed Bio
Establishes integrated, large molecule discovery platform.Contract Pharma Staff 01.04.21
-
Breaking News | Collaborations & Alliances | CRO News
PathoQuest, Charles River Expand Strategic Pact
Establishes a biologics genomic testing laboratory in Wayne, PA to expand next-generation sequencing capabilities.Contract Pharma Staff 11.12.20
-
Promotions & Moves
Altasciences Appoints Senior Director Compliance and RA
Paul will lead the development of the company’s regulatory offering, from preclinical to clinical research, for all services01.10.20
-
Biologics, Proteins, Vaccines | CRO News | Drug Discovery | Preclinical Outsourcing
Charles River to Acquire HemaCare Corp. for $380M
Expands scientific capabilities for cell and gene therapies12.16.19
-
Biologics, Proteins, Vaccines | Breaking News | CRO News | Drug Discovery
Charles River, Bit Bio Enter Strategic Pact
Partnership will leverage Bit Bio’s unique ability to generate authentic human cells at scale12.10.19
-
Promotions & Moves
Altasciences Adds Bioanalytical Management Leader
LeSauteur joins the management team responsible for the Bioanalytical Services in the U.S. and the Ligand Binding team in Canada09.04.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Charles River & CHDI Extend Partnership
Five-year extension of their ongoing collaboration that started in 2005 for the drug discovery and development for Huntington’s disease04.11.19
-
Bio News | Industry News | Promotions & Moves
Metrion Appoints New CEO
Dr Andrew Southan has been with the company for three years, previously serving as COO, and has over 25 years of industry experience04.09.19
-
Breaking News | Collaborations & Alliances | Drug Discovery
Crown Bio, Charles River Enter Discovery Agreement
Enables greater global model availability for drug discovery in obesity, diabetes and metabolic syndrome03.12.19
-
Breaking News | CRO News | Industry News | Preclinical Outsourcing
-
Bio News | Industry News | Promotions & Moves | Toxicology
Smithers Avanza Appoints Business Development Director
Ms. Lyric Boyle has over 20 years of experience in preclinical discovery and development, including safety assessments in the chemical industries02.07.19
-
Breaking News | Drug Development | Drug Discovery | Toxicology
Charles River, ToxTracker In Tox Assay Alliance
To offer access to ToxTracker to quickly screen chemicals for genotoxicity01.31.19
-
Laboratory Testing
Necessary, Appropriate, Valid: A mantra for facility managers creating complete health strategies
The challenge of maintaining colony health; the importance of health monitoringEmmanuel Gomas, European Services Manager, Envigo 11.13.18
-
Analytical Services | Breaking News | Collaborations & Alliances | Drug Discovery | Information Technology
Charles River, Distributed Bio in Exclusive Antibody Discovery Pact
Gains access to Distributed Bio’s antibody libraries and integrated antibody optimization technologies10.25.18
-
Breaking News | Drug Discovery | Industry News | R&D
Charles River Awarded $95.7M NIH Contract
Will provide staffing for NIAID’s on-site vivarium and related research model operations10.17.18
-
R&D
-
CRO News | Drug Discovery | Industry News
Charles River Expands Early Discovery Services
Adds high-throughput technologies and expanded pharmacokinetic services05.01.18
-
Drug Discovery | Preclinical Outsourcing
Preclinical Partnerships
Bill Barbo of Charles River discusses drug discovery and outsourcing trends in today’s market04.10.18
-
CRO News | Drug Discovery | Information Technology
Charles River, PathoQuest Expand Strategic Biologics Pact
Charles River will provide clients access to PathoQuest’s NGS-based testing solutions04.09.18
-
Drug Development | Preclinical Outsourcing | R&D
Advancing Rare Disease Research
How early research provides the crucial evidence needed to conduct clinical trialsKristin Brooks, Contract Pharma 03.05.18
-
Analytical Services | CRO News | Laboratory Testing | Preclinical Outsourcing | Toxicology
Charles River Pays $800M for MPI Research
Expands client base, service portfolio, and builds scale02.13.18
-
Breaking News | CRO News | Drug Discovery | Facilities
Charles River Invests in High-Throughput Screening Infrastructure
Signs collaboration agreement with AstraZeneca02.06.18
-
Drug Development | Drug Discovery | Preclinical Outsourcing
Outsourcing Early Drug Development
Birgit Girshick of Charles River discusses trends in the early discovery and development space01.17.18
-
Breaking News | CRO News | Drug Discovery | Industry News
Charles River Laboratories Buys KWS BioTest for $20M
Bolsters the CRO’s immunology contract research services01.12.18
-
CRO News | Drug Discovery | Preclinical Outsourcing
Charles River Acquires KWS BioTest
Expands discovery services for immuno-oncology, inflammatory, and infectious diseases01.11.18
-
Promotions & Moves
Atossa Genetics Names Scientific Advisor
Dr. Novina is a leading researcher in the field of RNAi therapeutics12.21.17
-
CRO News | Laboratory Testing | Preclinical Outsourcing
-
CRO News | Drug Development | Drug Discovery | Information Technology
-
Bioanalytical Services | Biosimilars
The Analytical Challenges of the Biosimilar Boom
The growing biosimilar industry and its implications on the current drug marketMario DiPaola, Senior Scientific Director, Charles River Laboratories 07.03.17
-
Drug Development | Drug Discovery | Preclinical Outsourcing
Overcoming Preclinical Drug Development Hurdles
Aidan Synnott of Charles River Laboratories discusses the latest developments in oncology research modelsKristin Brooks, Contract Pharma 05.02.17
-
Collaborations & Alliances | Drug Development | Drug Discovery | Laboratory Testing | Preclinical Outsourcing | R&D
Nimbus Therapeutics, Charles River in Strategic R&D Alliance
Will work to advance programs in immunology, metabolic disorders and oncology from discovery through to IND04.05.17
-
Drug Discovery | Industry News | Preclinical Outsourcing
Charles River Launches Oncology Research Model
NCG model is the first CRISPR-generated immunodeficient model offered by the company04.03.17
-
Collaborations & Alliances | Drug Development | Drug Discovery | Preclinical Outsourcing
Charles River, Chiesi Extend Drug Discovery Alliance
Will provide integrated drug discovery services to help identify and test Chiesi’s candidates03.13.17
-
Analytical Services | Laboratory Testing
Analytical Testing Outsourcing Trends Update
Spurred by many factors, global analytical testing services market is experiencing rapid growth in the range of 11% per year01.26.17
-
Financial Reports
Financial Report: Charles River Laboratories
WIL Research and Oncotest acquisitions boost revenues11.02.16
-
CRO News | Drug Discovery | Preclinical Outsourcing
Charles River Acquires Agilux Labs
Adds integrated discovery capabilities to nonclinical portfolio09.29.16
-
Capsules | Clinical Trials
-
Biosimilars | Breaking News | CRO News | Drug Development | Industry News | Validation
Charles River Acquires Blue Stream Labs
Offers clients an integrated portfolio for biologic and biosimilar drug development06.28.16
-
Financial Reports
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News | Preclinical Outsourcing
-
APIs | Chemistry | Clinical Trials | Drug Delivery | Drug Development | Industry News | Injectables | Process Development
Consolidation in Outsourcing
Reviewing 2015’s M&A activityMichael A. Martorelli, Fairmount Partners 03.09.16
-
Clinical Trials | CRO News | Drug Development | Drug Discovery | Laboratory Testing
-
Collaborations & Alliances | Drug Development | Drug Discovery
Charles River Expands MJFF Parkinson’s Pact
Aims to further advance efforts to identify novel small molecule LRRK2 inhibitors12.08.15
-
Drug Discovery | Industry News | Preclinical Outsourcing | Validation
Charles River Acquires Oncotest
Expands oncology portfolio with target discovery and validation services11.19.15
-
Supply Chain | Vials
Spying on the Bugs
Environmental monitoring and the quest to keep biopharmaceutical products safe.Christine Farrance , Accugenix 09.11.15
-
Analytical Services | Breaking News | CRO News | QA/QC
Charles River, AstraZeneca Extend Strategic Partnership
Charles River remains sole provider of safety assessment and development DMPK07.30.15
-
Analytical Services | Breaking News | Chemistry | Drug Discovery | Financial Reports | Laboratory Testing | Preclinical Outsourcing
Financial Report: Charles River Laboratories
Safety Assessment and EMD businesses are primary drivers of growth in the quarter07.30.15
-
Breaking News | Methods Development | Promotions & Moves
-
Analytical Services | Breaking News | Industry News | QA/QC
Charles River Buys Celsis International
Enhances portfolio for rapid quality control testing07.09.15
-
Biosimilars | Chemistry | Fill/Finish
Setting a Precedent for Biosimilars in the U.S.
Niall Dinwoodie of Charles River discusses several key industry issues on biosimilars and addresses some of the development and regulatory hurdles that remainKristin Brooks, Contract Pharma 05.19.15
-
Breaking News | Drug Discovery | Financial Reports | Methods Development
-
Bioassay Development | Breaking News | Clinical Trials | CRO News | Drug Development | Laboratory Testing | Methods Development | Process Development | Toxicology
-
Microbiology | Process Validation | Validation
Insight into the Growing Microbiology Market
Foster Jordan of Charles River discusses key technologies and trendsKristin Brooks, Associate Editor 03.10.15
-
APIs | Clinical Trials | Drug Discovery | Industry News
Consolidation in Outsourcing
Reviewing 2014’s M&A activityMichael A. Martorelli , Director, Fairmount Partners 03.06.15
-
Bioassay Development | Breaking News | Clinical Trials | CRO News | Drug Development | GMPs/GCPs | Methods Development | Process Development | Promotions & Moves | Toxicology
Charles River Makes Management Changes
Smith to succeed Ackerman, Hickey takes on Global Discovery Services02.25.15
-
Breaking News | Financial Reports
Financial Report: Charles River Laboratories
Discovery and manufacturing services drive growth02.11.15
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Discovery | Methods Development
CHDI, Charles River Extend Huntington’s Discovery Pact
Will provide research activities for another five years11.10.14
-
Breaking News | Financial Reports
Financial Report: Charles River Laboratories
Argenta and BioFocus acquisition drives growth in the quarter10.30.14
-
Microbiology | Process Validation | Validation
Strange Ally in the War Against Sepsis
50 years ago this year, scientists first connected an ancient sea creature to testing for life-threatening bacteriaAgnes Shanley , Editor 09.08.14
-
Breaking News | Financial Reports
-
Breaking News | Chemistry | CRO News | Drug Discovery | Methods Development
Charles River Completes Acquisition of Galapagos’ CRO Services
Stay tuned for Contract Pharma's Newsmaker interview with CEO, James Foster04.01.14
-
Breaking News | CRO News | R&D
Charles River Joins Exostar’s Life Sciences Community
Aims to facilitate collaborations, reduce costs, and accelerate R&DKristin Brooks 02.28.14
-
Logistics
Charles River Offers New Service Model for QC Testing
Q&A with Birgit Girshick about the insourcing/outsourcing service for pharma and biopharmaKristin Brooks 02.25.14
-
Breaking News | CRO News | Drug Development | Extractables and Leachables | Facilities | GMPs/GCPs | Industry News | Laboratory Testing | Methods Development | Process Development | QA/QC | Validation
Charles River Launches RightSource Service
Allows companies to outsource biologic QC testingKristin Brooks 02.20.14
-
Breaking News | Financial Reports
Financial Report: Charles River Laboratories
PCS segment sales up 8% in the quarterKristin Brooks 02.12.14
-
Bioassay Development | Capsules | Clinical Trials | Drug Development | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Methods Development | Process Development | Toxicology
Consolidation in Outsourcing
Reviewing 2013’s M&A activityMichael A. Martorelli, Fairmount Partners 01.22.14
-
Breaking News | Promotions & Moves
Charles River Makes Organizational Changes
Aims to meet client needs for flexibility, efficiencyKristin Brooks 12.09.13
-
Chemistry | Clinical Trials | Drug Development | Drug Discovery | Extractables and Leachables | Facilities | GMPs/GCPs | Methods Development | Preclinical Outsourcing | Process Development | QA/QC | R&D | Toxicology | Validation
The Wild West of Basic Discovery
R&D outsourcing issuesNancy Gillett, Charles River Laboratories 11.13.13
-
Breaking News | Drug Discovery | Laboratory Testing
-
Breaking News | Chemistry | Promotions & Moves
-
Breaking News | Clinical Trials | CRO News | Drug Development | GMPs/GCPs | Industry News | Laboratory Testing
BioStorage Expands into China
Partners with Charles River Labs to expand sample management in the region10.10.13
-
Breaking News | Financial Reports | Promotions & Moves
Charles River Appoints Corporate Controller
Crowley to provide strategic guidance to the finance groups09.27.13
-
Breaking News | Clinical Trials | Collaborations & Alliances | CRO News | GMPs/GCPs | Inspections | Laboratory Testing | Preclinical Outsourcing | Regulatory Affairs
-
Breaking News | Financial Reports
-
Breaking News | CRO News | Drug Development | Promotions & Moves | Toxicology
-
Breaking News | CRO News | Financial Reports
-
Biosimilars | Clinical Trials | Drug Development | Formulation Development | Process Development | Supply Chain | Toxicology | Vials
Biosimilars Update
When will we see legal generics of top biopharmaceuticals?Gil Roth, Contract Pharma 04.03.13
-
Breaking News | Financial Reports
-
Breaking News | Promotions & Moves | Regulatory Affairs
-
Breaking News | Drug Development | Drug Discovery | Industry News
-
Breaking News | Financial Reports
-
Bioassay Development | Breaking News | Clinical Trials | Collaborations & Alliances | CRO News | Drug Development | GMPs/GCPs | Methods Development | Preclinical Outsourcing | Process Development | Toxicology
Charles River, AstraZeneca in Strategic Partnership
Three-year pact covers safety assessment, development DMPKGil Roth 10.17.12
-
Drug Development | Microbiology | Validation | Vials
Charles River’s Endotoxin Play
CRL’s Foster Jordan on acquiring AccugenixGil Y. Roth, Contract Pharma 10.09.12
-
Breaking News | Chemistry | Industry News
Charles River Opens Diagnostic Testing Facility
Expands diagnostic capabilities for research services09.06.12
-
Analytical Services | Bioanalytical Services | Bioassay Development | Breaking News | CRO News | GMPs/GCPs | Industry News | Inspections | Laboratory Testing | Microbiology | Process Validation | Regulatory Affairs | Toxicology
Charles River Acquires Accugenix
$17 mil. deal adds to endotoxin, microbial portfolioGil Roth 08.29.12
-
Breaking News | Financial Reports
-
Biosimilars | Drug Development | Drug Discovery | Preclinical Outsourcing | Toxicology
Online Extra: Preclinical Perspectives
Providers look to a brighter futureKristin Brooks, Contract Pharma 05.30.12
-
Analytical Services | Aseptic Processing | Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Biosimilars | Capsules | Clinical Trial Materials | Clinical Trials | Drug Development | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Inspections | Logistics | Lyophilization | Methods Development | Process Development | QA/QC | R&D | Regulatory Affairs | Scale-up/Technology Transfer | Serialization | Supply Chain | Toxicology | Validation
Biosimilar Outsourcing Update
FDA’s draft guidance leads to new opportunitiesGil Roth, Contract Pharma 05.04.12
-
Breaking News | Clinical Trials | CRO News | Financial Reports | GMPs/GCPs | Preclinical Outsourcing
Financial Reports: Charles River 1Q
Preclinical revenues drop, offset by RMS uptickGil Roth 05.03.12
-
Analytical Services | Bioanalytical Services | Bioassay Development | Breaking News | Collaborations & Alliances | Laboratory Testing | Toxicology | Validation
Charles River Licenses EMD Millipore Technology
Will integrate TrueSpike into viral clearance services02.27.12
-
Breaking News | CRO News | Financial Reports
Financial Report: Charles River Laboratories
RMS segment sales were up, while PCS segment sales declined02.14.12
-
Breaking News | CRO News | Promotions & Moves
-
Analytical Services | Bioanalytical Services | Breaking News | Chemistry | Toxicology
-
Biosimilars | Breaking News
-
Breaking News | Drug Development | Preclinical Outsourcing
Charles River Unifies RMS and PCS Businesses
Aims to improve client access to products and services08.24.11
-
Biosimilars | Drug Development | Drug Discovery | Preclinical Outsourcing | Toxicology
Newsmakers Q&A: Nancy Gillett of Charles River Laboratories
Managing preclinical operationsGil Y. Roth 06.06.11
-
Breaking News | Financial Reports
Charles River Laboratories 1Q11
Sales were down 7% in the Preclinical Services (PCS) segment to $112.5 million.05.04.11
-
Breaking News | Industry News
Charles River To Supply Pfizer’s Research Models
Charles River Laboratories and Pfizer have entered into a marketing and distribution agreement to provide certain Pfizer-developed genetically modified research models to the biomedical research community.03.03.11
-
Breaking News | Financial Reports
-
Breaking News | Drug Discovery | Preclinical Outsourcing | R&D | Toxicology
-
Bioassay Development | Chemistry | Clinical Trials | Drug Development | GMPs/GCPs | Information Technology | Laboratory Testing | Methods Development | Preclinical Outsourcing | Process Development | R&D | Toxicology
Outsourcing M&A Year In Review
Reviewing 2010�s mergers, acquisitions and buyoutsMichael A. Martorelli 01.24.11
-
Breaking News | Industry News
Charles River Outlines Business Plans
Charles River Laboratories International, Inc. released its business outlook, highlighting its portfolio and its plan to focus on four key initiatives in an effort to drive shareholder value.12.14.10
-
Breaking News | Collaborations & Alliances | Drug Discovery
Charles River, Transposagen in Rat Pact
Charles River Laboratories has entered into an exclusive, long-term marketing and distribution agreement with Transposagen Biopharmaceuticals, Inc., a KY-based provider of genetically modified rat models.10.14.10
-
Breaking News | Collaborations & Alliances | Drug Development
Charles River Offers Genotox Screening Test
Charles River Laboratories has partnered with Gentronix to offer BlueScreen HC Screening services for the early detection of genotoxicity.09.16.10
-
Financial Reports | Industry News | Preclinical Outsourcing | Toxicology
-
Breaking News | Financial Reports
-
Breaking News | Industry News
Charles River, WuXi Terminate Acquisition Agreement
Charles River Laboratories and WuXi PharmaTech, Inc. have decided to terminate their previously announced acquisition agreement.07.30.10
-
Chemistry | Preclinical Outsourcing | Toxicology
Business Combinations
Recent transactions reflect different strategiesMichael A. Martorelli 06.01.10
-
Chemistry | Clinical Trials | Drug Development | Drug Discovery | Preclinical Outsourcing | Toxicology
-
Clinical Trials | Drug Development | Toxicology | Validation
-
Breaking News | Chemistry | Drug Development | Industry News | Toxicology
Charles River To Acquire WuXi PharmaTech
Charles River Laboratories will acquire WuXi PharmaTech for approximately $1.6 billion.04.26.10
-
Breaking News | Chemistry | Drug Development | Industry News | Toxicology
Charles River Shanghai Gets OECD Certification
Charles River Laboratories' Shanghai facility has received a Certificate of Good Laboratory Practice (GLP) compliance from the Organization for Economic Cooperation and Development (OECD).04.15.10
-
Drug Development | Preclinical Outsourcing | Toxicology
-
Breaking News | Collaborations & Alliances
Chiltern, Charles River Enter Radiolabelled Drug Pact
Chiltern International and Charles River Laboratories have entered into a collaboration under which Chiltern Early Phase will partner with Charles River to conduct and support radiolabelled studies.02.23.10
-
Breaking News | Industry News
Charles River To Suspend Preclinical Ops in MA
Charles River Laboratories has decided to suspend operations at its Preclinical Services (PCS) facility in Shrewsbury, MA by mid-2010, once ongoing studies are completed.01.12.10
-
Breaking News | Industry News
Charles River Lays Off 115
Charles River Laboratories has laid off 115 workers from its CTBR Bio-Research unit near Montreal10.19.09
-
Clinical Trials | Drug Development | Drug Discovery | Information Technology
-
Breaking News | Promotions & Moves
-
Breaking News | Financial Reports
Financial Report: Charles River Laboratories 2Q
Sales declined in both the Research Models and Services (RMS) and Preclinical Services (PCS) segments, reflecting the negative impact of foreign exchange, as well as softer market demand.08.05.09
-
Breaking News | Drug Development | Promotions & Moves | Toxicology
Charles River
Charles River Laboratories has made changes within its Research Models and Services (RMS) and Preclinical Services (PCS) and Sales organizations.07.01.09
-
Clinical Trials | Drug Development | Drug Discovery | Validation
-
Analytical Services | Bioanalytical Services | Bioassay Development | Biosimilars | Chemistry | Clinical Trials | Drug Development | Drug Discovery | Toxicology
-
Breaking News | Drug Development | Industry News
PPD Sells Piedmont Center, Buys Magen Biosciences
PPD, Inc. has entered into a definitive agreement to sell its wholly-owned subsidiary Piedmont Research Center, LLC to Charles River Laboratories for $46.0 million in cash.04.03.09
-
Breaking News | Financial Reports
Financial Report: Charles River Laboratories 4Q
Preclinical Services (PCS) segment revenue was $158.6 million (-8%) due to slower market demand and the negative impact of foreign exchange.02.10.09
-
Breaking News | Promotions & Moves
-
Breaking News | Drug Development | Industry News
-
Breaking News | Drug Discovery | Promotions & Moves
-
Breaking News | Drug Development | Drug Discovery | Industry News
-
Breaking News | Promotions & Moves
-
Breaking News | Promotions & Moves
-
Breaking News | Industry News | Toxicology
-
Breaking News | Promotions & Moves
-
Breaking News | Financial Reports
-
Chemistry | Drug Development | Financial Reports
Consolidation in Outsourcing
Our annual report chronicling the M&A activity in the outsourcing sector in 2006Michael Martorelli 01.26.07
-
Analytical Services | Bio News | Bioanalytical Services | Toxicology | Validation
-
Analytical Services | Bioanalytical Services | Breaking News | Industry News
-
Breaking News | Promotions & Moves
-
Breaking News | Collaborations & Alliances
-
APIs | Chemistry | Clinical Trials | Drug Development
Consolidation in Outsourcing
Our financial analyst sums up 2005's big movesMichael Martorelli 01.24.06
-
Breaking News | Promotions & Moves
-
Chemistry | Drug Development | Drug Discovery | Information Technology | Process Development | Process Validation | Risk Management | Validation
Industry Consolidation
Our year-end review of merger & acquisition activityMichael A. Martorelli 08.23.05
-
Microbiology | Process Validation | Validation
Insight into the Growing Microbiology Market
Foster Jordan of Charles River discusses key technologies and trendsKristin Brooks 11.30.-1
